140 related articles for article (PubMed ID: 22155239)
1. Structural basis of anthrax edema factor neutralization by a neutralizing antibody.
Makiya M; Dolan M; Agulto L; Purcell R; Chen Z
Biochem Biophys Res Commun; 2012 Jan; 417(1):324-9. PubMed ID: 22155239
[TBL] [Abstract][Full Text] [Related]
2. Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding.
Chen Z; Moayeri M; Zhao H; Crown D; Leppla SH; Purcell RH
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13487-92. PubMed ID: 19651602
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
Kelly-Cirino CD; Mantis NJ
Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
[TBL] [Abstract][Full Text] [Related]
5. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
[TBL] [Abstract][Full Text] [Related]
6. Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.
Thullier P; Avril A; Mathieu J; Behrens CK; Pellequer JL; Pelat T
PLoS One; 2013; 8(5):e65855. PubMed ID: 23741517
[TBL] [Abstract][Full Text] [Related]
7. Mouse monoclonal antibodies to anthrax edema factor protect against infection.
Leysath CE; Chen KH; Moayeri M; Crown D; Fattah R; Chen Z; Das SR; Purcell RH; Leppla SH
Infect Immun; 2011 Nov; 79(11):4609-16. PubMed ID: 21911463
[TBL] [Abstract][Full Text] [Related]
8. Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.
Evans MC; Phung P; Paquet AC; Parikh A; Petropoulos CJ; Wrin T; Haddad M
BMC Bioinformatics; 2014 Mar; 15():77. PubMed ID: 24646213
[TBL] [Abstract][Full Text] [Related]
9. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.
Nguyen ML; Terzyan S; Ballard JD; James JA; Farris AD
Infect Immun; 2009 Nov; 77(11):4714-23. PubMed ID: 19720758
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen-Deuterium Exchange Mass Spectrometry Reveals a Novel Binding Region of a Neutralizing Fully Human Monoclonal Antibody to Anthrax Protective Antigen.
Fang M; Wang Z; Norris K; James JA; Wu S; Smith K
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202120
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
Taft SC; Weiss AA
Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into the neutralization of cytotoxic abrin by the monoclonal antibody D6F10.
Bagaria S; Ponnalagu D; Bisht S; Karande AA
PLoS One; 2013; 8(7):e70273. PubMed ID: 23922965
[TBL] [Abstract][Full Text] [Related]
13. Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.
Reason D; Liberato J; Sun J; Keitel W; Zhou J
Infect Immun; 2009 May; 77(5):2030-5. PubMed ID: 19223482
[TBL] [Abstract][Full Text] [Related]
14. N-fragment of edema factor as a candidate antigen for immunization against anthrax.
Zeng M; Xu Q; Hesek ED; Pichichero ME
Vaccine; 2006 Jan; 24(5):662-70. PubMed ID: 16157430
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.
McComb RC; Martchenko M
Vaccine; 2016 Jan; 34(1):13-9. PubMed ID: 26611201
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel multiepitope chimeric vaccine against anthrax.
Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R
Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
Clement KH; Rudge TL; Mayfield HJ; Carlton LA; Hester A; Niemuth NA; Sabourin CL; Brys AM; Quinn CP
Clin Vaccine Immunol; 2010 Nov; 17(11):1753-62. PubMed ID: 20739500
[TBL] [Abstract][Full Text] [Related]
18. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of neutralization of a human anti-α-toxin antibody.
Oganesyan V; Peng L; Damschroder MM; Cheng L; Sadowska A; Tkaczyk C; Sellman BR; Wu H; Dall'Acqua WF
J Biol Chem; 2014 Oct; 289(43):29874-80. PubMed ID: 25210036
[TBL] [Abstract][Full Text] [Related]
20. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
